Basic Information
The Global Drug Commercialization Center (GDCC) is headquartered in Vancouver, Canada. GDCC possesses a global project collection network and a unique scientific and commercial committee, enabling it to efficiently and rapidly identify truly groundbreaking and innovative technology projects from the global biopharmaceutical project system for commercial development. In April 2017, GDCC, Chengdu Biocity Equity Investment Co., Ltd., Chengdu Technology Transfer Venture Capital Co., Ltd., and Sichuan Sanxin Venture Capital Co., Ltd. jointly funded the establishment of Global Biomedical Industry Development (Chengdu) Co., Ltd. (also known as GDCC China Center).